Posted On: 03/27/2014 10:14:13 AM
Post# of 5066
BMSN should be on par with ACTC share price wise should FDA give approval to HemaXellerate I and with DCellVax IND submission. Both in the stem cell business with almost same huge share structure. Can BMSN get to that level? Jury is out on that.
(0)
(0)
